CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Self System Therapy for Older Adults with Advanced Lung Cancer (SST-LC) Resiliencebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04825912
NCT04825912N/ACompleted

Resilience Measurement, Prediction, and Its Role in Older Adults With Late-Stage Lung Cancer

Duke University·interventional·Posted Apr 1, 2021·Updated Feb 2, 2024

In Brief

A clinical study evaluating Self System Therapy for Older Adults with Advanced Lung Cancer (SST-LC) Resilience for Lung Cancer Stage III and Lung Cancer Stage IV. Completed, enrolled 18 participants across 1 site.

Detailed Summary

The purpose of this study to test measures of physical and psychological resilience while using Self-System therapy (SST), to treat depression and lung-cancer-related distress in older adults (65 years and older).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 1, 2021
Enrollment StartMay 3, 2021
Primary CompletionMar 18, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.3 years ago

Interventions

Self System Therapy for Older Adults with Advanced Lung Cancer (SST-LC) Resiliencebehavioral

The SST-LC is a brief structured intervention deliverable by video conference. The SST-LC Resilience protocol will incorporate behavioral strategies designed to meet the needs of older adults with lung cancer, including examining individual and shared expectations for lung cancer care, identifying discrepancies between expectations and realistic possibilities, and modifying stress-exacerbating behaviors. The focus will be to test measures of resilience during the intervention period.